HF  Deerfield Management Company, L.P.


     Office Locations:

780 Third Avenue, 37th Floor
New York, NY 10017
Phone: 212-551-1600
Fax: 212-599-3075

Get all office locations for this firm with a National Database subscription or New York Database subscription.


  • Growth



  • Life Sciences & Healthcare
  • Medical Device



    Deerfield Management Company, L.P. is an employee owned hedge fund sponsor. The firm manages funds in excess of $7 billion. A portion of all profits from the Deerfield funds are donated to the Deerfield Foundation, including all profits from selected funds. It invests in public and private equity markets of the United States. The firm makes its private equity investments in large cap and growth companies. It typically invests in healthcare sector which includes pharmaceuticals, biotechnology, generic drugs, over the counter drugs, medical devices, medical equipment, diagnostics, hospital supplies, hospital services, acute care hospitals, nursing homes, psychiatric hospitals, alternate site providers, home care, physician practice management, medical software HMOs, health insurers, benefit management companies, distributors, drug stores, and animal healthcare products and services



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Howie Furst M.D. Partner
    James E. Flynn Managing Partner
    Karen Heidelberger Chief Partnership and Communications Officer
    Paul Takats Partner


    Recent Funding Events (trailing 12 months):










      Series C


      Strata Oncology



      Series B





      Series B


      Constellation Pharmaceuticals








      Series C


      Dracen Pharmaceuticals



      Series A


      Pairwise Plants



      Series A


      Generation Bio



      Series B


      Braeburn Pharmaceuticals





      Quartet Health



      Series C


      Fractyl Labs



      Series D


      Blade Therapeutics



      Series B


      Homology Medicines



      Series B


    Portfolio companies include:


    Recent News: